Creating Next Generation Digitized Cancer Treatments
We are a Swedish digital health company that improves the lives of cancer patients by enhancing and supporting treatments with our innovative Digital Therapeutics (DTx) platform. We are pioneering digital therapeutics in the field of Oncology and Specialized Healthcare.
Values With Our Digital Therapeutics
Our DTx platform SciMedOne allows a close interaction between the patient and the healthcare team, including a systematic analysis of real-world facts relating to the treatment given. All centered around the patient’s experience and challenges, aiming to improve disease management in all aspects on an individual basis.
SciMedOne empowers patients, healthcare providers and payers with digital tools for addressing a wide range of cancer diseases through high quality, safe, and effective data-driven digital interventions.
Improved adherence, efficiency, and safety
Optimized and personalized treatment
Earlier symptom detection
Improved utilization of resources
Improved patient self-management
Less need for emergency medical care
Real World Data
Improved and safer therapies and drugs
Reimbursement and pricing decisions
Our DTx platform SciMedOne enables cancer care teams to manage, prioritize, and structure their follow-up of patients in a cost and time efficient way.
The patient has their own app, as a support and companion, that helps the individual to self-manage their health and keep in close contact with the health care team.
The patient also reports symptoms and health related data that gives the cancer care team valuable complementary information for better and faster decision making. This can include changes in drug prescription and dosage, scheduling of an earlier re-visit, and treatment changes.
How It Works
Cancer care team
Doctor or nurse prescribes a DTx app to patient and registers patient in SciMedOne platform
Patient downloads and onboards the DTx app
Patient registers continuously symptoms, medication intake, and health related data with engaging and supportive DTx app
Cancer care team works proactively and efficiently with patients and prioritize critical cases with SciMedOne platform that uses smart algorithms and real-time data
for optimal individualized results
Supports the patient journey
Focus on user experience and usability
Holistic 360-degree view on patient interventions
for optimal therapy support
Pre-defined disease and treatment configurations
Adaptations for personalized therapies
for improved patient management
Automated patient feedback loops
Support for patient prioritization management
Continuously improved based on real data and user feedback
Compliant and Secure
for regulatory complicance fullfilment
CE marked as medical device
Secure data management
Modern and Flexible
for future proof implementation
Modern and scalable cloud-based architecture
Integration with electronic health record systems and healthcare information systems
What the Patients Say
"I experience the use of the app positively. It is easy to use and contributes to a clear summary of my state of health and mood."
- Breast cancer patient
“I am very happy with the app! I especially appreciate getting the lab test results directly in my smartphone.”
- Blood cancer patient
"The possibility to check that I am taking my medication as I should is important! It happens that I miss it some day, then a reminder is worth its weight in gold."
- Breast cancer patient
We develop and evaluate together with leading medical research universities and healthcare providers digital therapeutics supporting various lifestyle interventions and prevention of diseases.
Examples of digital interventions include increased physical activity, smoking cessation, healthy diet, and engaging in self-care activities. Our DTx platform is used to achieve better health in such various areas as stroke prevention and obesity.
We also utilize the knowledge and clinical evidence from this field for further development and refinement of our digital therapeutics within oncology and hematology.
ScientificMed in Numbers
Number of ongoing or completed randomized controlled trials (RCTs) where our digital therapeutics have been evaluated
Hospitals and clinics
Number of hospitals and clinics in the Nordics where our digital therapeutics have been evaluated or implemented
Number of collaborations with top-tier pharmaceutical companies